Skip to main content
. 2011 May 3;104(11):1686–1690. doi: 10.1038/bjc.2011.151

Figure 2.

Figure 2

(Upper panel) Time to progression (all patients). (Lower panel) Time to progression of 26 patients treated with prior imatinib only and 19 patients with prior imatinib and sunitinib. Patients censored are indicated with a bar.